| Name | Title | Contact Details |
|---|
With a global footprint spanning Europe, North and South America, Asia, and Africa, Sodecia operates business units that partner with the worlds leading automakers to develop innovative products and services. We specialize in stamping and welding, producing high-quality automotive components. Our technology centers in Europe provide comprehensive collaborative engineering services, delivering solutions that add value through advanced technologies, sustainability, agility, simplicity, and customer satisfaction. Sustainability is at the heart of our operations. We are committed to reducing our environmental impact through various initiatives, including the implementation of cutting-edge technologies and sustainable practices. Our dedication to sustainability ensures that we are not only meeting the needs of today but also preserving resources for future generations. At Sodecia, we believe in continuous improvement and innovation. Our global team is dedicated to enhancing the quality of life through the development of solutions for the automotive sector. Together, we are driving forward to create a safer, more efficient, and sustainable future. Explore more about our mission and values on our website.
MedVet is the leading veterinarian owned and led network of specialty and emergency hospitals dedicated to delivering exceptional care and a deeply supportive experience to pets and their loving families, referring veterinarians, and team members. For more than 35 years, MedVets empathetic, insightful, and driven team of expert caregivers has helped the organization grow to be the preferred choice for high quality, compassionate care, proudly serving more than 500,000 patients each year in communities throughout the United States. Our caregivers are deeply committed to MedVets mission of Leading Specialty Healthcare for Pets and our driven by our core values of Teamwork, Leadership, and Compassion. Visit www.medvet.com for further information and to view employment opportunities at MedVet. MedVet is an Equal Opportunity Employer.
Net Zero Since Day Zero. The ABB FIA Formula E World Championship brings dramatic racing to the heart of some of the worlds most iconic cities providing an elite motorsport platform for the worlds leading automotive manufacturers to accelerate electric vehicle innovation. The Formula E network of teams, manufacturers, partners, broadcasters, and host cities are united by a passion for the sport and belief in its potential to accelerate sustainable human progress and create a better future for people and planet.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.